載入...

Study protocol: multicenter double-blind, randomized, placebo-controlled trial of rituximab for the treatment of childhood-onset early-stage uncomplicated frequently relapsing or steroid-dependent nephrotic syndrome (JSKDC10 trial)

BACKGROUND: Eighty percent of children with idiopathic nephrotic syndrome respond well to steroid therapy, but up to 50% of patients with steroid-sensitive nephrotic syndrome exhibit frequently relapsing (FRNS) or steroid-dependent nephrotic syndrome (SDNS). Several studies identified the chimeric a...

全面介紹

Na minha lista:
書目詳細資料
發表在:BMC Nephrol
Main Authors: Nagano, China, Sako, Mayumi, Kamei, Koichi, Ishikura, Kenji, Nakamura, Hidefumi, Nakanishi, Koichi, Omori, Takashi, Nozu, Kandai, Iijima, Kazumoto
格式: Artigo
語言:Inglês
出版: BioMed Central 2019
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6679488/
https://ncbi.nlm.nih.gov/pubmed/31375087
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-019-1470-3
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!